Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Pharmacological Assessment of Sepiapterin Reductase Inhibition on Tactile Response in the Rat.

Meyer JT, Sparling BA, McCarty WJ, Zhang M, Soto M, Schneider S, Chen H, Roberts J, Tan H, Kornecook T, Andrews PS, Knutson CG.

J Pharmacol Exp Ther. 2019 Nov;371(2):476-486. doi: 10.1124/jpet.119.257105. Epub 2019 May 20.

PMID:
31110114
2.

Strategies for calibrating models of biology.

Read MN, Alden K, Timmis J, Andrews PS.

Brief Bioinform. 2018 Sep 18. doi: 10.1093/bib/bby092. [Epub ahead of print]

3.

Evaluating the effectiveness and implementation of evidence-based treatment: A multisite hybrid design.

Ashmore JA, Ditterich KW, Conley CC, Wright MR, Howland PS, Huggins KL, Cooreman J, Andrews PS, Nicholas DR, Roberts L, Hewitt L, Scales JN, Delap JK, Gray CA, Tyler LA, Collins C, Whiting CM, Brothers BM, Ryba MM, Andersen BL.

Am Psychol. 2019 May-Jun;74(4):459-473. doi: 10.1037/amp0000309. Epub 2018 Jul 19.

PMID:
30024215
4.

Macrophage Transactivation for Chemokine Production Identified as a Negative Regulator of Granulomatous Inflammation Using Agent-Based Modeling.

Moyo D, Beattie L, Andrews PS, Moore JWJ, Timmis J, Sawtell A, Hoehme S, Sampson AT, Kaye PM.

Front Immunol. 2018 Mar 27;9:637. doi: 10.3389/fimmu.2018.00637. eCollection 2018.

5.

Extending and Applying Spartan to Perform Temporal Sensitivity Analyses for Predicting Changes in Influential Biological Pathways in Computational Models.

Alden K, Timmis J, Andrews PS, Veiga-Fernandes H, Coles M.

IEEE/ACM Trans Comput Biol Bioinform. 2017 Mar-Apr;14(2):431-442. doi: 10.1109/TCBB.2016.2527654. Epub 2016 Feb 11.

PMID:
26887007
6.

Correction: Determining disease intervention strategies using spatially resolved simulations.

Read M, Andrews PS, Timmis J, Williams RA, Greaves RB, Sheng H, Coles M, Kumar V.

PLoS One. 2015 May 8;10(5):e0128170. doi: 10.1371/journal.pone.0128170. eCollection 2015. No abstract available.

7.

Utilising a simulation platform to understand the effect of domain model assumptions.

Alden K, Andrews PS, Veiga-Fernandes H, Timmis J, Coles M.

Nat Comput. 2015;14(1):99-107.

8.

Using argument notation to engineer biological simulations with increased confidence.

Alden K, Andrews PS, Polack FA, Veiga-Fernandes H, Coles MC, Timmis J.

J R Soc Interface. 2015 Mar 6;12(104):20141059. doi: 10.1098/rsif.2014.1059.

9.

Modelling biological behaviours with the unified modelling language: an immunological case study and critique.

Read M, Andrews PS, Timmis J, Kumar V.

J R Soc Interface. 2014 Oct 6;11(99). pii: 20140704. doi: 10.1098/rsif.2014.0704.

10.

Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitors.

Hua Z, Bregman H, Buchanan JL, Chakka N, Guzman-Perez A, Gunaydin H, Huang X, Gu Y, Berry V, Liu J, Teffera Y, Huang L, Egge B, Emkey R, Mullady EL, Schneider S, Andrews PS, Acquaviva L, Dovey J, Mishra A, Newcomb J, Saffran D, Serafino R, Strathdee CA, Turci SM, Stanton M, Wilson C, Dimauro EF.

J Med Chem. 2013 Dec 27;56(24):10003-15. doi: 10.1021/jm401317z. Epub 2013 Dec 11.

PMID:
24294969
11.

Determining disease intervention strategies using spatially resolved simulations.

Read M, Andrews PS, Timmis J, Williams RA, Greaves RB, Sheng H, Coles M, Kumar V.

PLoS One. 2013 Nov 14;8(11):e80506. doi: 10.1371/journal.pone.0080506. eCollection 2013. Erratum in: PLoS One. 2015;10(5):e0128170.

12.

In silico investigation into dendritic cell regulation of CD8Treg mediated killing of Th1 cells in murine experimental autoimmune encephalomyelitis.

Williams RA, Greaves R, Read M, Timmis J, Andrews PS, Kumar V.

BMC Bioinformatics. 2013;14 Suppl 6:S9. doi: 10.1186/1471-2105-14-S6-S9. Epub 2013 Apr 17.

13.

Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors.

Bregman H, Chakka N, Guzman-Perez A, Gunaydin H, Gu Y, Huang X, Berry V, Liu J, Teffera Y, Huang L, Egge B, Mullady EL, Schneider S, Andrews PS, Mishra A, Newcomb J, Serafino R, Strathdee CA, Turci SM, Wilson C, DiMauro EF.

J Med Chem. 2013 Jun 13;56(11):4320-42. doi: 10.1021/jm4000038. Epub 2013 May 23.

PMID:
23701517
14.

In silico investigation of novel biological pathways: the role of CD200 in regulation of T cell priming in experimental autoimmune encephalomyelitis.

Greaves RB, Read M, Timmis J, Andrews PS, Butler JA, Gerckens BO, Kumar V.

Biosystems. 2013 May;112(2):107-21. doi: 10.1016/j.biosystems.2013.03.007. Epub 2013 Mar 7.

PMID:
23499816
15.

Spartan: a comprehensive tool for understanding uncertainty in simulations of biological systems.

Alden K, Read M, Timmis J, Andrews PS, Veiga-Fernandes H, Coles M.

PLoS Comput Biol. 2013;9(2):e1002916. doi: 10.1371/journal.pcbi.1002916. Epub 2013 Feb 28. Erratum in: PLoS Comput Biol. 2013 Aug;9(8). doi:10.1371/annotation/cfcaffb6-8515-4595-b6cc-85b84703d7d5.

16.

Functional complexity of the Leishmania granuloma and the potential of in silico modeling.

Moore JW, Moyo D, Beattie L, Andrews PS, Timmis J, Kaye PM.

Front Immunol. 2013 Feb 15;4:35. doi: 10.3389/fimmu.2013.00035. eCollection 2013.

17.

Engineering simulations for cancer systems biology.

Bown J, Andrews PS, Deeni Y, Goltsov A, Idowu M, Polack FA, Sampson AT, Shovman M, Stepney S.

Curr Drug Targets. 2012 Nov;13(12):1560-74. Review.

PMID:
22974398
18.

Pairing experimentation and computational modeling to understand the role of tissue inducer cells in the development of lymphoid organs.

Alden K, Timmis J, Andrews PS, Veiga-Fernandes H, Coles MC.

Front Immunol. 2012 Jul 18;3:172. doi: 10.3389/fimmu.2012.00172. eCollection 2012.

19.

Discovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitors.

Peterson EA, Boezio AA, Andrews PS, Boezio CM, Bush TL, Cheng AC, Choquette D, Coats JR, Colletti AE, Copeland KW, DuPont M, Graceffa R, Grubinska B, Kim JL, Lewis RT, Liu J, Mullady EL, Potashman MH, Romero K, Shaffer PL, Stanton MK, Stellwagen JC, Teffera Y, Yi S, Cai T, La DS.

Bioorg Med Chem Lett. 2012 Aug 1;22(15):4967-74. doi: 10.1016/j.bmcl.2012.06.033. Epub 2012 Jun 16.

PMID:
22765895
20.

The discovery and optimization of a novel class of potent, selective, and orally bioavailable anaplastic lymphoma kinase (ALK) inhibitors with potential utility for the treatment of cancer.

Lewis RT, Bode CM, Choquette DM, Potashman M, Romero K, Stellwagen JC, Teffera Y, Moore E, Whittington DA, Chen H, Epstein LF, Emkey R, Andrews PS, Yu VL, Saffran DC, Xu M, Drew A, Merkel P, Szilvassy S, Brake RL.

J Med Chem. 2012 Jul 26;55(14):6523-40. doi: 10.1021/jm3005866. Epub 2012 Jul 10.

PMID:
22734674
21.

Development of a homogeneous AlphaLISA ubiquitination assay using ubiquitin binding matrices as universal components for the detection of ubiquitinated proteins.

Schneider S, Chen H, Tang J, Emkey R, Andrews PS.

Biochim Biophys Acta. 2012 Nov;1823(11):2038-45. doi: 10.1016/j.bbamcr.2012.03.018. Epub 2012 Apr 5.

22.

Ubiquitin ligase substrate identification through quantitative proteomics at both the protein and peptide levels.

Lee KA, Hammerle LP, Andrews PS, Stokes MP, Mustelin T, Silva JC, Black RA, Doedens JR.

J Biol Chem. 2011 Dec 2;286(48):41530-8. doi: 10.1074/jbc.M111.248856. Epub 2011 Oct 10.

23.

Discovery of triazine-benzimidazoles as selective inhibitors of mTOR.

Peterson EA, Andrews PS, Be X, Boezio AA, Bush TL, Cheng AC, Coats JR, Colletti AE, Copeland KW, DuPont M, Graceffa R, Grubinska B, Harmange JC, Kim JL, Mullady EL, Olivieri P, Schenkel LB, Stanton MK, Teffera Y, Whittington DA, Cai T, La DS.

Bioorg Med Chem Lett. 2011 Apr 1;21(7):2064-70. doi: 10.1016/j.bmcl.2011.02.007. Epub 2011 Feb 12.

PMID:
21376583
24.

Identification of substrates of SMURF1 ubiquitin ligase activity utilizing protein microarrays.

Andrews PS, Schneider S, Yang E, Michaels M, Chen H, Tang J, Emkey R.

Assay Drug Dev Technol. 2010 Aug;8(4):471-87. doi: 10.1089/adt.2009.0264.

PMID:
20804422
25.

Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein interaction.

Allen JG, Bourbeau MP, Wohlhieter GE, Bartberger MD, Michelsen K, Hungate R, Gadwood RC, Gaston RD, Evans B, Mann LW, Matison ME, Schneider S, Huang X, Yu D, Andrews PS, Reichelt A, Long AM, Yakowec P, Yang EY, Lee TA, Oliner JD.

J Med Chem. 2009 Nov 26;52(22):7044-53. doi: 10.1021/jm900681h.

PMID:
19856920
26.

Assays for RING family ubiquitin ligases.

Furukawa M, Andrews PS, Xiong Y.

Methods Mol Biol. 2005;301:37-46.

PMID:
15917624
27.

Drosophila Morgue is an F box/ubiquitin conjugase domain protein important for grim-reaper mediated apoptosis.

Wing JP, Schreader BA, Yokokura T, Wang Y, Andrews PS, Huseinovic N, Dong CK, Ogdahl JL, Schwartz LM, White K, Nambu JR.

Nat Cell Biol. 2002 Jun;4(6):451-6.

PMID:
12021772
28.

Diagonal earlobe creases and atheromatous disease: a postmortem study.

Patel V, Champ C, Andrews PS, Gostelow BE, Gunasekara NP, Davidson AR.

J R Coll Physicians Lond. 1992 Jul;26(3):274-7.

29.

Improve your hospital autopsy rate to 40-50 per cent, a tale of two towns.

Champ C, Tyler X, Andrews PS, Coghill SB.

J Pathol. 1992 Apr;166(4):405-7.

PMID:
1517894
30.

The pathology of cot deaths.

Herbert A, Andrews PS.

J Pathol. 1979 May;128(1):39-48.

PMID:
469651
31.

Cot deaths and malnutrition: the role of dehydration.

Andrews PS.

Med Sci Law. 1975 Jan;15(1):47-50. No abstract available.

PMID:
1219308
32.

Two cases of endocardial fibroelastosis--possible x-linked determination.

Lindenbaum RH, Andrews PS, Khan AS.

Br Heart J. 1973 Jan;35(1):38-40. No abstract available.

33.

The consultant's job.

Medhurst GA, Andrews PS.

Lancet. 1969 Jul 26;2(7613):210-1. No abstract available.

PMID:
4183152
34.

Effects of sulphated degraded laminarin on experimental tumour growth.

JOLLES B, REMINGTON M, ANDREWS PS.

Br J Cancer. 1963 Mar;17:109-15. No abstract available.

35.

Chronic Q fever. 2. Morbid anatomical and bacteriological findings in a patient with endocarditis.

ANDREWS PS, MARMION BP.

Br Med J. 1959 Nov 14;2(5158):983-8. No abstract available.

36.
37.

Chondromalacia of the patella.

WILES P, ANDREWS PS, DEVAS MB.

J Bone Joint Surg Br. 1956 Feb;38-B(1):95-113. No abstract available.

PMID:
13295323

Supplemental Content

Loading ...
Support Center